Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Ending Cash Position : €1,620 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ending Cash Position?

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Ending Cash Position for the quarter that ended in Mar. 2025 was €1,620 Mil.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's quarterly Ending Cash Position increased from Sep. 2024 (€1,964 Mil) to Dec. 2024 (€2,138 Mil) but then declined from Dec. 2024 (€2,138 Mil) to Mar. 2025 (€1,620 Mil).

Guangzhou Baiyunshan Pharmaceutical Holdings Co's annual Ending Cash Position declined from Dec. 2022 (€2,817 Mil) to Dec. 2023 (€2,546 Mil) and declined from Dec. 2023 (€2,546 Mil) to Dec. 2024 (€2,138 Mil).

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ending Cash Position Historical Data

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ending Cash Position Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

2,233.10

2,919.76

2,817.05

2,545.89

2,138.44

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															2,343.53	1,853.15	1,964.06	2,138.44	1,620.39

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2600.228	+	-461.793
	=	2,138

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2080.231	+	-459.84
	=	1,620

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Guangzhou Baiyunshan Pharmaceutical Holdings Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (FRA:GU5) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

GZPHF:USA 00874:Hong Kong GU5:Germany 600332:China

Address

45 Sha Mian North Street, Liwan District, Guangdong Province, Guangzhou, CHN, 510130

Website

https://www.gybys.com.cn

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segments include Great Southern TCM; Great Health; Great Commerce and Great Medical Care. The company generates maximum revenue from the Great Commerce segment.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Headlines

No Headlines